Boothbay Fund Management’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-45,057
| Closed | -$14.9K | – | 2292 |
|
|
2023
Q1 | $14.9K | Hold |
45,057
| – | – | ﹤0.01% | 1817 |
|
|
2022
Q4 | $32.4K | Hold |
45,057
| – | – | ﹤0.01% | 1655 |
|
|
2022
Q3 | $54K | Sell |
45,057
-4,740
| -10% | -$5.68K | ﹤0.01% | 1823 |
|
|
2022
Q2 | $59K | Hold |
49,797
| – | – | ﹤0.01% | 1797 |
|
|
2022
Q1 | $108K | Hold |
49,797
| – | – | ﹤0.01% | 1693 |
|
|
2021
Q4 | $74K | Hold |
49,797
| – | – | ﹤0.01% | 1582 |
|
|
2021
Q3 | $145K | Sell |
49,797
-3,244
| -6% | -$9.45K | ﹤0.01% | 1462 |
|
|
2021
Q2 | $175K | Hold |
53,041
| – | – | 0.01% | 1402 |
|
|
2021
Q1 | $199K | Hold |
53,041
| – | – | 0.01% | 1130 |
|
|
2020
Q4 | $187K | Buy |
+53,041
| New | +$187K | 0.01% | 947 |
|
|
2018
Q3 | – | Sell |
-8,080
| Closed | -$596K | – | 874 |
|
|
2018
Q2 | $596K | Buy |
+8,080
| New | +$596K | 0.05% | 207 |
|